Silencing of A-kinase anchor protein 4 inhibits the metastasis and growth of non-small cell lung cancer

References

• Herbst RS, Morgensztern D, Boshoff C. The biology and management of non-small cell lung cancer. Nature. 2018;553:446–454.
   PubMed Web of Science ®Google Scholar
• Kris MG, Johnson BE, Berry LD, et al. Using multiplexed assays of oncogenic drivers in lung cancers to select targeted drugs. JAMA. 2014;311:1998–2006.
   PubMed Web of Science ®Google Scholar
• Jurisic V, Obradovic J, Pavlovic S, et al. Epidermal growth factor receptor gene in non-small-cell lung cancer: the importance of promoter polymorphism investigation. Anal Cell Pathol. 2018;2018:6192187.
   Web of Science ®Google Scholar
• Jurisic V, Vukovic V, Obradovic J, et al. EGFR polymorphism and survival of NSCLC patients treated with TKIs: a systematic review and meta-analysis. J Oncol. 2020;2020:1973241.
   PubMed Web of Science ®Google Scholar
• Rapoport AP, Stadtmauer EA, Binder-Scholl GK, et al. NY-ESO-1-specific TCR-engineered T cells mediate sustained antigen-specific antitumor effects in myeloma. Nat Med. 2015;21:914–921.
   PubMed Web of Science ®Google Scholar
• Sakai K, Shimodaira S, Maejima S, et al. Dendritic cell-based immunotherapy targeting Wilms’ tumor 1 in patients with recurrent malignant glioma. J Neurosurg. 2015;123:989–997.
   PubMed Web of Science ®Google Scholar
• Lynch TJ, Bondarenko I, Luft A, et al. Ipilimumab in combination with paclitaxel and carboplatin as first-line treatment in stage IIIB/IV non-small-cell lung cancer: results from a randomized, double-blind, multicenter phase II study. J Clin Oncol. 2012;30:2046–2054.
   PubMed Web of Science ®Google Scholar
• Ma W, Gilligan BM, Yuan J, et al. Current status and perspectives in translational biomarker research for PD-1/PD-L1 immune checkpoint blockade therapy. J Hematol Oncol. 2016;9:47.
   PubMed Web of Science ®Google Scholar
• Dronca RS, Liu X, and Harrington SM, et al. T cell Bim levels reflect responses to anti-PD-1 cancer therapy. JCI Insight. 2016 May 5;1(6): e86014.
   Web of Science ®Google Scholar
• Dasgeb B, Mehregan D, Ring C, et al. Cancer-testis antigens as biomarkers for Merkel cell carcinoma: pitfalls and opportunities. J Cutan Pathol. 2019;46:748–752.
   PubMed Web of Science ®Google Scholar
• Grizzi F, Mirandola L, Qehajaj D, et al. Cancer-testis antigens and immunotherapy in the light of cancer complexity. Int Rev Immunol. 2015;34:143–153.
   PubMed Web of Science ®Google Scholar
• Park TS, Groh EM, Patel K, et al. Expression of MAGE-A and NY-ESO-1 in primary and metastatic cancers. J immunother (Hagerstown, Md: 1997). 2016;39:1–7.
   PubMed Web of Science ®Google Scholar
• Lavergne V, Ghannoum M, Weiss K, et al. Successful prevention of respiratory syncytial virus nosocomial transmission following an enhanced seasonal infection control program. Bone Marrow Transplant. 2011;46:137–142.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Saini S, Parashar D, et al. The novel cancer-testis antigen A-kinase anchor protein 4 (AKAP4) is a potential target for immunotherapy of ovarian serous carcinoma. Oncoimmunology. 2013;2:e24270.
   PubMed Web of Science ®Google Scholar
• Agarwal S, Saini S, Parashar D, et al. Expression and humoral response of A-kinase anchor protein 4 in cervical cancer. Int J Gynecol Cancer. 2013;23:650–658.
   PubMed Web of Science ®Google Scholar
• Mirandola L, Yu Y, Jenkins MR, et al. Tracking human multiple myeloma xenografts in NOD-Rag-1/IL-2 receptor gamma chain-null mice with the novel biomarker AKAP-4. BMC Cancer. 2011;11:394.
   PubMed Web of Science ®Google Scholar
• Saini S, Jagadish N, Gupta A, et al. A novel cancer testis antigen, A-kinase anchor protein 4 (AKAP4) is a potential biomarker for breast cancer. PLoS One. 2013;8:e57095.
   PubMed Web of Science ®Google Scholar
• Chiriva-Internati M, Yu Y, Mirandola L, et al. Identification of AKAP-4 as a new cancer/testis antigen for detection and immunotherapy of prostate cancer. Prostate. 2012;72:12–23.
   PubMed Web of Science ®Google Scholar
• Gumireddy K, Li A, Chang DH, et al. AKAP4 is a circulating biomarker for non-small cell lung cancer. Oncotarget. 2015;6:17637–17647.
   PubMed Web of Science ®Google Scholar
• Lin X, Bai D, Wei Z, et al. Curcumin attenuates oxidative stress in RAW264.7 cells by increasing the activity of antioxidant enzymes and activating the Nrf2-Keap1 pathway. PloS One. 2019;14:e0216711.
   PubMed Web of Science ®Google Scholar
• Jurisic V. Multiomic analysis of cytokines in immuno-oncology. Expert Rev Proteomics. 2020;17:663–674.
   PubMed Web of Science ®Google Scholar
• Vieth M, Kushima R, Mukaisho K, et al. Immunohistochemical analysis of pyloric gland adenomas using a series of Mucin 2, Mucin 5AC, Mucin 6, CD10, Ki67 and p53. Virchows Arch. 2010;457:529–536.
   PubMed Web of Science ®Google Scholar
• Jurisic V, Srdic-Rajic T, Konjevic G, et al. TNF-alpha induced apoptosis is accompanied with rapid CD30 and slower CD45 shedding from K-562 cells. J Membr Biol. 2011;239:115–122.
   PubMed Web of Science ®Google Scholar
• Gentile MT, Pastorino O, Bifulco M, et al. HUVEC tube-formation assay to evaluate the impact of natural products on angiogenesis. J Vis Exp. 2019. DOI:10.3791/58591
   PubMed Web of Science ®Google Scholar
• Justus CR, Leffler N, Ruiz-Echevarria M, et al. In vitro cell migration and invasion assays. J Vis Exp. 2014. DOI:10.3791/51046
   PubMed Web of Science ®Google Scholar
• Ma Y, Ren Y, Dai ZJ, et al. IL-6, IL-8 and TNF-alpha levels correlate with disease stage in breast cancer patients. Adv Clin Exp Med. 2017;26:421–426.
   PubMed Web of Science ®Google Scholar
• Yan C, Brunson DC, Tang Q, et al. Visualizing engrafted human cancer and therapy responses in immunodeficient zebrafish. Cell. 2019;177:1903–14 e14.
   PubMed Web of Science ®Google Scholar
• Tavakoli Koudehi A, Mahjoubi B, Mirzaei R, et al. AKAP4, SPAG9 and NY-ESO-1 in Iranian colorectal cancer patients as probable diagnostic and prognostic biomarkers. Asian Pac J Cancer Prev. 2018;19:463–469.
   PubMedGoogle Scholar
• Jagadish N, Parashar D, Gupta N, et al. A-kinase anchor protein 4 (AKAP4) a promising therapeutic target of colorectal cancer. J Exp Clin Cancer Res. 2015;34:142.
   PubMed Web of Science ®Google Scholar
• Kumar V, Jagadish N, Suri A. Role of A-Kinase anchor protein (AKAP4) in growth and survival of ovarian cancer cells. Oncotarget. 2017;8:53124–53136.
   PubMedGoogle Scholar
• Jiang K, Yao G, Hu L, et al. MOB2 suppresses GBM cell migration and invasion via regulation of FAK/Akt and cAMP/PKA signaling. Cell Death Dis. 2020;11:230.
   PubMed Web of Science ®Google Scholar
• Wang S, Zhang Z, Qian W, et al. Angiogenesis and vasculogenic mimicry are inhibited by 8-Br-cAMP through activation of the cAMP/PKA pathway in colorectal cancer. Onco Targets Ther. 2018;11:3765–3774.
   PubMed Web of Science ®Google Scholar
• Manning G, Whyte DB, Martinez R, et al. The protein kinase complement of the human genome. Science. 2002;298:1912–1934.
   PubMed Web of Science ®Google Scholar
• van der Flier S, Chan CM, Brinkman A, et al. BCAR1/p130Cas expression in untreated and acquired tamoxifen-resistant human breast carcinomas. Int J Cancer. 2000;89:465–468.
   PubMed Web of Science ®Google Scholar
• Malbon CC, Tao J, Wang HY. AKAPs (A-kinase anchoring proteins) and molecules that compose their G-protein-coupled receptor signalling complexes. Biochem J. 2004;379:1–9.
   PubMed Web of Science ®Google Scholar
• Malbon CC, Tao J, Shumay E, et al. AKAP (A-kinase anchoring protein) domains: beads of structure-function on the necklace of G-protein signalling. Biochem Soc Trans. 2004;32:861–864.
   PubMed Web of Science ®Google Scholar